Synthesis, evaluation, and crystallographic analysis of L-371,912: A potent and selective active-site thrombin inhibitor

被引:51
作者
Lyle, TA
Chen, ZG
Appleby, SD
Freidinger, RM
Gardell, SJ
Lewis, SD
Li, Y
Lyle, EA
Lynch, JJ
Mulichak, AM
Ng, AS
NaylorOlsen, AM
Sanders, WM
机构
[1] MERCK SHARP & DOHME RES LABS,DEPT BIOL CHEM,W POINT,PA 19486
[2] MERCK SHARP & DOHME RES LABS,DEPT MOL DESIGN & DIVERS,W POINT,PA 19486
[3] MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,W POINT,PA 19486
关键词
D O I
10.1016/S0960-894X(96)00583-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Removal of the beta-ketoamide functionality from L370,518 (K-i = 0.09 nM) provided a 5 nM K-i inhibitor of thrombin: L-371,912. Comparison of the enzyme-inhibitor crystal structures suggests a possible explanation for the relatively small change in affinity for thrombin. L-371,912 is selective for thrombin over related serine proteases and is efficacious in an animal model of arterial thrombosis. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:67 / 72
页数:6
相关论文
共 13 条
  • [11] Lyle T., 1993, PERSPECT DRUG DISCOV, V1, P453
  • [12] CHAIN - A CRYSTALLOGRAPHIC MODELING PROGRAM
    SACK, JS
    [J]. JOURNAL OF MOLECULAR GRAPHICS, 1988, 6 (04): : 224 - 225
  • [13] SYNTHETIC LOW-MOLECULAR-WEIGHT THROMBIN INHIBITORS - MOLECULAR DESIGN AND PHARMACOLOGICAL PROFILE
    TAPPARELLI, C
    METTERNICH, R
    EHRHARDT, C
    COOK, NS
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (10) : 366 - 376